Advertisement
Home Authors Posts by HealthDay.com

HealthDay.com

HealthDay.com
38592 POSTS 0 COMMENTS

American Society of Anesthesiologists, Oct. 24-28

0
ANESTHESIOLOGY 2015 The annual meeting of the American Society of Anesthesiologists was held from Oct. 24 to 28 in San Diego and attracted...
In a new study on how often medication errors occur during surgery

ASA: Peri-Op Medication Errors Far Too Common

0
And most of the mistakes are preventable, researchers report
Concurrent use of heroin and prescription opioids is increasing

More Prescription Opioid Addicts Are Turning to Heroin

0
Interviews with addicts confirm desire for cheaper, more plentiful substitute
Type 2 diabetes still substantially increases mortality risk

Despite Progress, Mortality Still Risk Up in Patients With T2DM

0
Risks vary per age, glycemic control, and renal complications
Lynparza (olaparib) targets mutations found in about 30 percent of men with prostate cancer

Ovarian Cancer Rx Promising for Prostate Tumors

0
In small study, olaparib targeted gene mutation in men who had failed other therapy
For patients with acute myocardial infarction

Part D Enrollment Doesn’t Improve Outcomes After AMI

0
Half of AMI patients enrolled in Part D by hospital discharge; outcomes no better than non-enrollees
For patients with rheumatoid arthritis and inflammatory bowel disease with prior nonmelanoma skin cancer (NMSC)

Some RA Treatments Up Second Nonmelanoma Skin Cancer Risk

0
Increased risk with methotrexate, and for anti-TNF drugs in conjunction with methotrexate
Computed tomography findings affect the diagnosis and management of suspected community-acquired pneumonia

Early CT Scan Impacts Management of Suspected CAP

0
CT scan modified classification in 58.6 percent of patients presenting to ER with suspected CAP
For patients with liver cirrhosis

Low-Dose Rifaximin Cuts Endotoxin Level in Cirrhosis

0
Similar reduction in serum endotoxin level for low-dose, high-dose rifaximin
Cancer-associated incidental pulmonary embolism should be treated with low molecular weight heparins

Review Supports LMWH for Cancer-Linked Incidental PE

0
VTE recurrence risk similar under LMWHs, vitamin K antagonists; risk of major hemorrhage up under VKA